Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 202189 78 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103214455A reveals a mild hypochlorite oxidation route for Bilastine, offering high yield and purity for reliable pharmaceutical intermediate supply chains.